Detalhe da pesquisa
1.
Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer.
Cell Rep
; 43(5): 114174, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700982
2.
A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast Cancer.
Cancer Res
; 82(20): 3668-3670, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245246
3.
The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals Key Functions in Splicing and Gene Expression Regulation.
Cancer Res
; 82(12): 2269-2280, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442400